BlackRock, Inc. 13D and 13G filings for Harmony Biosciences Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY |
BlackRock Inc. BLK |
6,968,097 12.200% |
965,723 (+16.09%) |
Filing |
| 2024-01-24 2:27 pm Sale |
2023-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY |
BlackRock Inc. BLK |
6,002,374 10.200% |
-129,160 (-2.11%) |
Filing |
| 2023-10-06 2:34 pm Purchase |
2023-09-30 | 13G | Harmony Biosciences Holdings, Inc. HRMY |
BlackRock Inc. BLK |
6,131,534 10.200% |
1,262,705 (+25.93%) |
Filing |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY |
BlackRock Inc. BLK |
4,868,829 8.200% |
1,129,063 (+30.19%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY |
BlackRock Inc. BLK |
3,739,766 6.400% |
3,739,766 (New Position) |
Filing |